✦ LIBER ✦

FDA comments on phase I clinical trials without vector biodistribution data

✍ Scribed by Epstein, Suzanne; Bauer, Steven; Miller, Andra; Pilaro, Anne; Noguchi, Philip

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study of the Efficacy, Biodistribution,

✍ Muhammad, A K M G; Puntel, M; Candolfi, M; Salem, A; Yagiz, K; Farrokhi, C; Kroe 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 641 KB

Safety profile, efficacy, and biodistrib

✍ Puntel, Mariana; A.K.M., Ghulam Muhammad; Farrokhi, Catherine; VanderVeen, Natha 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 717 KB

Editorial Comment on: Randomized Phase I

✍ Christopher G. Eden 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Editorial Comment on: Randomized Phase I

✍ Paolo Gontero 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Phase I/II trial evaluating combined rad

✍ B.S Teh; G.E Ayala; W Mai; M.T Vlachaki; J Caillouet; M Davis; M.M Wheeler; T.M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 21 KB